China Money Network
Login
Join

Singapore’s GIC Leads $260M Series B Round In Chinese Biopharma Company CStone

  • May 9, 2018 — 14:20 CST

This Data Is Locked!

This area is available only to Subscribers.

GIC, the Singapore investment firm managing the state’s foreign reserves, has led a US$260 million (RMB1.653 billion) series B financing in CStone, a Chinese bio-pharmaceutical... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: